help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 14, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0898
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/2/616    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, H.
Right arrow Articles by Maruo, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, H.
Right arrow Articles by Maruo, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Uterine Cancer
*Uterine Fibroids

Submitted on April 26, 2006
Accepted on November 7, 2006

A Novel Selective Progesterone Receptor Modulator Asoprisnil activates Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Signaling Pathway in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells

Hiroko Sasaki, Noriyuki Ohara, Qin Xu, Jiayin Wang, Deborah A DeManno, Kristof Chwalisz, Shigeki Yoshida, and Takeshi Maruo*

Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan, and TAP Pharmaceutical Products Inc., Lake Forest, Illinois, 60045, USA

* To whom correspondence should be addressed. E-mail: maruo{at}kobe-u.ac.jp.

Context: We previously demonstrated that asoprisnil, a selective progesterone receptor modulator, induces apoptosis of cultured uterine leiomyoma cells. This study was conducted to evaluate whether asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptotic pathway in cultured uterine leiomyoma and matching myometrial cells.

Objective and Methods: After subculture in phenol red-free DMEM supplemented with 10% fetal bovine serum for 120 h, cultured cells were stepped down to serum-free conditions for 24 h in the absence or presence of graded concentrations of asoprisnil. The levels of TRAIL signaling molecules and cellular inhibitors of apoptosis protein (c-IAPs) were assessed by Western blot analysis.

Results: TRAIL contents in untreated cultured leiomyoma cells were significantly (P < 0.01) lower compared with those in untreated cultured myometrial cells. There was no difference in death receptor (DR) 4 and DR5 contents between the two types of cells. Asoprisnil treatment significantly (P < 0.05) increased TRAIL, DR4, and DR5 contents in cultured leiomyoma cells in a dose-dependent manner with a cleavage of caspase-8, -7, and -3, and decreased X-linked chromosome-linked IAP (XIAP) contents. In cultured myometrial cells, however, asoprisnil treatment did not affect either TRAIL signaling molecule or c-IAP contents. The concomitant treatment with 100 ng/mL P4 significantly (P < 0.05) reversed asoprisnil-induced increase in DR4 and cleaved poly(adenosine 5'-disphophate-ribose) contents in cultured leiomyoma cells.

Conclusions: These results suggest that asoprisnil induces apoptosis of cultured leiomyoma cells by activating TRAIL-mediated apoptotic pathway and down-regulating XIAP levels in the absence of comparable effects on myometrial cells.




This article has been cited by other articles:


Home page
Hum ReprodHome page
A. Morikawa, N. Ohara, Q. Xu, K. Nakabayashi, D. A. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo
Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer
Hum. Reprod., April 1, 2008; 23(4): 944 - 951.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
M. A. Behera, L. Feng, B. Yonish, W. Catherino, S.-H. Jung, and P. C. Leppert
Thrombospondin-1 and Thrombospondin-2 mRNA and TSP-1 and TSP-2 Protein Expression in Uterine Fibroids and Correlation to the Genes COL1A1 and COL3A1 and to the Collagen Cross-link Hydroxyproline
Reproductive Sciences, December 1, 2007; 14(8_suppl): 63 - 76.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Yin, Z. Lin, Y.-H. Cheng, E. E. Marsh, H. Utsunomiya, H. Ishikawa, Q. Xue, S. Reierstad, J. Innes, S. Thung, et al.
Progesterone Receptor Regulates Bcl-2 Gene Expression through Direct Binding to Its Promoter Region in Uterine Leiomyoma Cells
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4459 - 4466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. Xu, N. Ohara, J. Liu, K. Nakabayashi, D. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo
Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1002 - E1011.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society